Multiprofessional Critical Care Review: Adult 2024 (MCCRCA24ON)-Question and Answer Session 2

Pdf Summary

In this scenario, the patient is presenting with signs and symptoms consistent with ethylene glycol toxicity. Laboratory findings of metabolic acidosis, elevated liver enzymes, and oxalate crystalluria support this diagnosis. The most appropriate treatment for ethylene glycol toxicity is fomepizole, a potent inhibitor of alcohol dehydrogenase. N-acetylcysteine, activated charcoal, and methylene blue are not indicated for the treatment of ethylene glycol toxicity.

Meta Tag

Concept Pheochromocytoma

Concept Cushing Syndrome

Concept Propofol-Related Infusion Syndrome

Concept D-lactic acidosis

Concept Alpha-Adrenergic Blockade

Keywords

ethylene glycol toxicity

signs and symptoms

metabolic acidosis

elevated liver enzymes

oxalate crystalluria

fomepizole

alcohol dehydrogenase inhibitor

N-acetylcysteine

activated charcoal

methylene blue

Pheochromocytoma

Cushing Syndrome

Propofol-Related Infusion Syndrome

D-lactic acidosis

Alpha-Adrenergic Blockade

	Society of Critical Care Medicine 500 Midway Drive Mount Prospect, IL 60056 USA Phone: +1 847 827-6888 Fax: +1 847 439-7226 Email: support@sccm.org	Contact Us About SCCM Newsroom Advertising & Sponsorship DONATE	MySCCM LearnICU Patients & Families Surviving Sepsis Campaign Critical Care Societies Collaborative	GET OUR NEWSLETTER
© Society of Critical Care Medicine. All rights reserved. \| Privacy Statement \| Terms & Conditions The Society of Critical Care Medicine, SCCM, and Critical Care Congress are registered trademarks of the Society of Critical Care Medicine.